Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS)

  • 14 Accesses

  • 2 Citations

Summary

We examined the regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with regressing or progressing canine transmissible venereal sarcomas (CTVS). Both regressor and progressor peripheral blood leukocytes (PBL), draining and nondraining lymph node cells (LNC), and splenic leukocytes were significantly responsive to CTVS antigen extract in tube LAI. In contrast, a significant decrease in basal glass adherence of progressor PBL, draining and nondraining LNC, and splenic leukocytes was observed. Normal glass adherence was restored to progressor leukocytes by extensive washing with warm serum-free media, while significant tube LAI responsiveness to CTVS antigen extract was maintained. Preincubation of regressor PBL and LNC with progressor sera in two-stage tube LAI decreased the basal glass adherence of treated leukocytes. This effect of progressor sera was heat labile, a characteristic of CTVS antigen. Collectively, these findings suggest that progessor leukocytes and progressor sera treated regressor leukocytes were activated by interaction with serum CTVS antigen and thus behaved in tube LAI as stimulated cells, even in the absence of CTVS antigen. Regressor but not progressor sera were shown to contain anti-CTVS IgG with specific arming activity for normal dog PBL, but not LNC in two-stage tube LAI. The nonadherent response of peripheral blood neutrophils in two-stage tube LAI was proportional to the concentration of arming IgG, whereas no change was observed in glass adherence of PBL. The results of this study define the role of progressor and regressor serum factors in the mechanism of tube LAI and demonstrate a relationship between leukocyte glass adherence and the clinical course of CTVS. These findings show that tube LAI is a simple and reproducible measure of active factors in the immune response to a tumor.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Beschorner WE, Hess AD, Nerenberg ST, Epstein RB (1979) Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factor. Cancer Res 39:3920

  2. 2.

    Cohen D (1973) The biological behavior of the transmissible venereal tumor in immunosuppressed dogs. Europ J Cancer 9:253

  3. 3.

    Fahey JL, Terry EW (1973) Ion exchange chromatography and gel filtration. In: Handbook of Experimental Immunology. Weir DM (ed) Oxford, Blackwell Press p. 7.1

  4. 4.

    Garvey, JS, Cremer NE, Sussdorf DH (1977) Methods in Immunology, Reading, MA, Benjamin WA Inc. pp. 218–328

  5. 5.

    Goldrosen MH, Russo AJ, Howell JH, Leveson SH, Holyoke ED (1979) Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction. Cancer Res 39:587

  6. 6.

    Grosser N, Thomson DMP (1975) Cell mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res 35:2571

  7. 7.

    Grosser N, Thomson DMP (1976) Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. III. Blockade of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients. Int J Cancer 18:58

  8. 8.

    Grosser N, Marti JH, Proctor JW, Thomson DMP (1976) Tube leukocyte adherence inhibition assay for the detection of antitumor immunity. I. Monocyte is the reactive cell. Int J Cancer 18:39

  9. 9.

    Halliday WJ, Miller S (1972) Leukocyte adherence inhibition: a simple test for cell-mediated tumor immunity and serum blocking factors. Int J Cancer 9:477

  10. 10.

    Halliday WJ, Maluish AE, Miller S (1974) Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leukocyte adherence inhibition test. Cell Immunol 10:467

  11. 11.

    Halliday WJ, Koppi TA, Khan JM, Davis NC (1980) Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer. J Natl Cancer Inst 65:327

  12. 12.

    Halliday WJ, Koppi TA, McKenzie IFC (1982) Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors. J Natl Cancer Inst 69:939

  13. 13.

    Harding MW, Yang TJ (1981) Canine transmissible venereal sarcoma: Leukocyte adherence inhibition (LAI) reactivity of various lymphoid tissues of dogs with tumors at different stages of growth. Int J Cancer 27:349

  14. 14.

    Harding MW, Yang TJ (1981) Sequential changes in peripheral blood leukocyte adherence inhibition (LAI) reactivity during progressive growth and spontaneous regression of canine transmissible venereal sarcoma. Int J Cancer 28:361

  15. 15.

    Harding MW, Yang TJ (1984) Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF). Cell Immunol 87:206

  16. 16.

    Harding MW, Palker TJ, Yang TJ (1983) Relationship between serum tumor antigen levels and leukocyte adherence inhibition (LAI) reactivity in dogs with canine transmissible venereal sarcoma. Fed Proc 31:807

  17. 17.

    Holan V, Hasek M, Bubenik J, Chutna J (1974) Antigen mediated macrophage adherence inhibition. Cell Immunol 13:107 (1975)

  18. 18.

    Holt PG, Roberts LM, Fimmel PJ, Keast D (1975) The LAI microtest: A rapid and sensitive procedure for the demonstration of cell-mediated immunity in vitro. J Immunol Methods 8:277

  19. 19.

    Koppi TA, Halliday WJ, McKenzie IFC (1981) Regulation of cell-mediated immunologic reactivity to Moloney sarcoma and virus-induced tumors. II. Nature of blocking and unblocking factors in serum. J Natl Cancer Inst 66:1097

  20. 20.

    Markwell MAK, Haas SM, Bieber LL, Tollbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206

  21. 21.

    Marti J, Thomson DMP (1976) Anti-tumor immunity in malignant melanoma assayed by tube leukocyte adherence inhibition. Br J Cancer 28:116

  22. 22.

    Marti JH, Grosser N, Thomson DMP (1976) Tube leukocyte adherence inhibition for the detection of anti-tumor immunity. II. Monocyte reacts with tumor antigen via cytophilic antitumor antibody. Int J Cancer 18:48

  23. 23.

    Meltzer MS, Leonard EJ, Rapp HJ, Borsos T (1971) Tumor specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst 47:703

  24. 24.

    Mortensen RF, Elson LM (1980) Suppression of the leukocyte adherence inhibition to murine sarcoma virus induced tumors by tumor-associated suppressor cells. Oncology 37:406

  25. 25.

    Mortensen RF, Elson LM (1980) Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. I. Cell requirements, specificity, lack of H-2 restriction, and role of antibody. J Immunol 124:2316

  26. 26.

    Palker TJ, Yang TJ (1981) Isolation, purification, and physicochemical characterization of a tumor associated antigen from the canine transmissible venereal sarcoma. J Natl Cancer Inst 66:779

  27. 27.

    Raina S, Russo AJ, Jenkins D, Goldrosen MH (1981) Role of T cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay. Cancer Res 31:3950

  28. 28.

    Russo AJ, Howell JH, Goldrosen MH (1981) Humoral factors involved in the mechanism of reactivity of the leukocyte adherence inhibition assay. Immunol Commun 10:611

  29. 29.

    Shani A, Ritts RE, Thynne GS, Weiland LH, Silvers A, Moertel CG (1978) A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int J Cancer 22:113

  30. 30.

    Shenouda G, Thomson DMP (1984) Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay. Cancer Res 44:2762

  31. 31.

    Shenouda G, Thomson DMP, MacFarlane JK (1984) Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays. Cancer Res 44:1238

  32. 32.

    Tanaka F, Sawada F, Yonemoto TH (1980) Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition. Gann 71:589

  33. 33.

    Taylor-Bennett B, Debelak-Fehir KM, Epstein RB (1975) Tumor blocking and inhibitory serum factors in the clinical course of canine venereal sarcoma. Cancer Res 35:2942

  34. 34.

    Thomson DMP, (ed) (1982) Assessment of immune status by the leukocyte adherence inhibition test. Academic Press New York

  35. 35.

    Thomson DMP, Grosser N (1979) Immunological mechanisms of tube leukocyte adherence inhibition. Cancer Res 39:576

  36. 36.

    Thomson DMP Tataryn DN, Schwartz R, MacFarlane JK (1979) Abrogation of the phenomenon of leukocyte adherence inhibition by excess circulating tumor antigen. Eur J Cancer 15:1095

  37. 37.

    Thomson DMP, Tataryn DN, Weatherhead JC, Friedlander P, Rauch J, Schwartz R, Gold P, Shuster J (1980) A human colon tumour antigen associated with B2-microglobulin and isolated from solid tumour, serum and urine, is unrelated to carcinoembryonic antigen. Eur J Cancer 16:539

  38. 38.

    Thomson DMP, Tataryn DN, Schwartz R (1980) Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumor-specific gamma globulin. Br J Cancer 41:86

  39. 39.

    Thomson DMP, Phelon J, Morton DG, Bach MK (1982) Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes. Int J Cancer 30:299

  40. 40.

    Yang TJ, Jones JB (1973) Canine transmissible venereal sarcoma: transplantation studies in neonatal and adult dogs. J Natl Cancer Inst 51:1915

Download references

Author information

Correspondence to Tsu-Ju (Thomas) Yang.

Additional information

This investigation was supported in part by grant, CA-23469, from the National Cancer Institute, DHHS, and is submitted as Scientific Contribution No. 1051, Storrs Agricultural Experiment Station, University of Connecticut, Storrs, CT 06268 USA

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Harding, M.W., Yang, T.(. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS). Cancer Immunol Immunother 19, 168–176 (1985). https://doi.org/10.1007/BF00199222

Download citation

Keywords

  • Immune Response
  • Sarcoma
  • Active Factor
  • Peripheral Blood Leukocyte
  • Lymph Node Cell